Late-Stage Radical (Radio)fluorosulfonylation of Amines with [19F]fluoride and [18F]fluoride
7 affiliations
- 1Hubei Research Center of Fundamental Science-Chemistry, Engineering Research Center of Organosilicon Compounds and Materials, Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China
- 2Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
- 3Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
- 4Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China
- 5Wuhan HTA Pharmaceutical Company Ltd., Wuhan 430075, China
- 6The Institute for Advanced Studies, Wuhan University, Wuhan 430072, China
- 7Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China
Abstract
Late-stage labeling with fluorine-18 serves to advance clinical care and drug discovery via positron emission tomography (PET). This goal motivates efforts to expand the accessible chemical space with tailored 18F-containing groups. Sulfamoyl fluorides are promising because of their potential physiological stability. Existing synthetic routes largely depend on group-transfer protocols from preformed fluorosulfonyl reagents. As a result, synthetic methods for [18F]sulfamoyl fluorides are fundamentally based on isotope exchange. None of the methods have enabled a no-carrier-added (NCA) protocol for radiofluorosulfonylation of amines. Herein, we provide nitrogen-centered radical-mediated assembling fluorosulfonylation reactions, enabling conversion of abundant NH-containing substrates into sulfamoyl fluorides with [19F]fluoride and [18F]fluoride as an exclusive fluorine source. Our method features high functional group tolerance, broad NH-substrates, and an NCA radiochemical technique. The initial preclinical evaluation of the freshly synthesized [18F]SUFA-flurpiridaz and its in vivo myocardial perfusion PET imaging collectively highlights the potential physiological stability of sulfamoyl [18F]fluoride groups and the potential application of our radical radiofluorosulfonylation strategy.
Related
- Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
- Development and internal validation of a clinicopathological and CT radiomics based prediction model for extracranial distant metastasis after radical resection in early-stage non-small cell lung cancer
- Real-World Guideline Concordance and Potential Overtreatment Following Primary Radical Hysterectomy for Early-Stage Cervical Cancer
- Cardiovascular disease-specific mortality after partial versus radical nephrectomy for stage II renal cancer: A SEER-based propensity-matched analysis
- The impact of extranodal spread on overall and recurrence-free survival in patients with clinically early-stage cervical cancer, but with tumor positive pelvic lymph nodes after radical hysterectomy
BibTeX
@article{wang2026latestage,
title = {{Late-Stage Radical (Radio)fluorosulfonylation of Amines with [19F]fluoride and [18F]fluoride}},
author = {Juanjuan Wang and Yiwei Huang and Zhiwei Xiao and Yong He and Yongkang Gai and Dan Xu and Kui Xu and Zhiqing Su and Xiao Shen and Qiang Cheng},
journal = {ACS central science},
year = {2026},
month = sep,
doi = {10.1021/acscentsci.6c00992},
url = {https://europepmc.org/article/PMC/PMC13720925},
note = {CC BY},
}
RIS
TY - JOUR
TI - Late-Stage Radical (Radio)fluorosulfonylation of Amines with [19F]fluoride and [18F]fluoride
AU - Juanjuan Wang
AU - Yiwei Huang
AU - Zhiwei Xiao
AU - Yong He
AU - Yongkang Gai
AU - Dan Xu
AU - Kui Xu
AU - Zhiqing Su
AU - Xiao Shen
AU - Qiang Cheng
PY - 2026
DA - 2026/09/17
JO - ACS central science
DO - 10.1021/acscentsci.6c00992
UR - https://europepmc.org/article/PMC/PMC13720925
AB - Late-stage labeling with fluorine-18 serves to advance clinical care and drug discovery via positron emission tomography (PET). This goal motivates efforts to expand the accessible chemical space with tailored 18F-containing groups. Sulfamoyl fluorides are promising because of their potential physiological stability. Existing synthetic routes largely depend on group-transfer protocols from preformed fluorosulfonyl reagents. As a result, synthetic methods for [18F]sulfamoyl fluorides are fundamentally based on isotope exchange. None of the methods have enabled a no-carrier-added (NCA) protocol for radiofluorosulfonylation of amines. Herein, we provide nitrogen-centered radical-mediated assembling fluorosulfonylation reactions, enabling conversion of abundant NH-containing substrates into sulfamoyl fluorides with [19F]fluoride and [18F]fluoride as an exclusive fluorine source. Our method features high functional group tolerance, broad NH-substrates, and an NCA radiochemical technique. The initial preclinical evaluation of the freshly synthesized [18F]SUFA-flurpiridaz and its in vivo myocardial perfusion PET imaging collectively highlights the potential physiological stability of sulfamoyl [18F]fluoride groups and the potential application of our radical radiofluorosulfonylation strategy.
SN - 2374-7943
SN - 2374-7951
ER -